Protalix BioTherapeutics, Inc. — Director's Dealing 2012

Jul 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protalix BioTherapeutics, Inc. (PLX)
CIK: 0001006281
Period of Report: 2012-07-16

Reporting Person: Lauterbach Sandra Leigh (VP, Sales & Commercial Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-16	Common Stock	A	20000	—	Acquired	20000	Indirect

Footnotes

F1: Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., issued under its 2006 Stock Incentive Plan, as amended June 17, 2012. The restricted shares vest in 12 equal quarterly increments over a three-year period, commencing on the date of grant.